retinopathy
-
André Larente on DIAGNOS’ Partnership with EssilorLuxottica to Expand AI Retinal Analysis and Offers Updates on Regulatory Approvals
September 09, 2024 — In a recent interview with InvestorNews host Pat Bolland, André Larente, President, CEO, and Director…
-
Eyes on DIAGNOS as commercialization gains momentum
The best time to buy an emerging company is when it begins commercialization. At this stage all the…
